Histone Lysine-to-Methionine Mutation as Anticancer Drug Target.

doi:10.1007/978-981-15-8104-5_7

Back to search

Article

Histone Lysine-to-Methionine Mutation as Anticancer Drug Target.

Advances in experimental medicine and biology - 1 Jan 2021

Yang Jianhong, Qiu Qiang, Chen Lijuan

Abstract excerpt

Histone modification stands for a vital genetic information form, which shows tight correlation with the modulation of normal physiological activities by genes. Abnormal regulation of histone methylation due to histone modification enzyme changes and histone mutations plays an important role in t...

Topics

Antineoplastic Agents
Chondroblastoma
Glioma
Histones
Humans
Lysine
Methionine
Mutation

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.